Octreotide Acetate Injection 500 mcg/mL recall: Particulate Matter
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for…
Why was Octreotide Acetate Injection 500 mcg/mL recalled?
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: AJ21002, Exp. 03/2024
- Product
- Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for…
- Recalling firm
- Viatris Inc
- Quantity
- 22400 syringes
- Distribution
- Nationwide in the USA
- Recall date
- November 16, 2022
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)